Patents by Inventor Axel Mescheder

Axel Mescheder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosages
    Publication number: 20230340110
    Abstract: The present invention relates to a treatment regime, including an antibody or antigen-binding fragment which is capable of binding specifically to colony stimulating factor-1 receptor (CSF-1R) for use in the treatment of tenosynovial giant cell tumour (TGCT) in a subject, as well as associated uses and methods.
    Type: Application
    Filed: November 1, 2022
    Publication date: October 26, 2023
    Applicant: Synox Therapeutics UK Limited
    Inventors: Axel Mescheder, Raymond Barlow, Michael Cannarile, Georgina Meneses-Lorente
  • Method of administering a cationic liposomal preparation
    Patent number: 9827196
    Abstract: The present invention relates to the use of pharmaceutical preparations comprising paclitaxel for administration to a human patient in need thereof.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: November 28, 2017
    Assignee: SynCore Biotechnology Co., Ltd.
    Inventors: Axel Mescheder, Matthias Karrasch
  • Treatment of Triple Receptor Negative Breast Cancer
    Publication number: 20170273934
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of “triple receptor negative” breast cancer.
    Type: Application
    Filed: June 12, 2017
    Publication date: September 28, 2017
    Applicant: SynCore Biotechnology Co., Ltd
    Inventors: Kay-Oliver Kliche, Axel Mescheder, Martine Piccart
  • Treatment of breast cancer
    Patent number: 9707204
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of “triple receptor negative” breast cancer.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: July 18, 2017
    Assignee: SYNCORE BIOTECHNOLOGY CO., LTD.
    Inventors: Kay-Oliver Kliche, Axel Mescheder, Martine Piccart
  • Method of Administering a Cationic Liposomal Preparation
    Publication number: 20160081929
    Abstract: The present invention relates to the use of pharmaceutical preparations comprising paclitaxel for administration to a human patient in need thereof.
    Type: Application
    Filed: December 4, 2015
    Publication date: March 24, 2016
    Inventors: Axel Mescheder, Matthias Karrasch
  • Method of administering a cationic liposomal preparation
    Patent number: 9233094
    Abstract: The present invention relates to the use of pharmaceutical preparations comprising paclitaxel for administration to a human patient in need thereof.
    Type: Grant
    Filed: May 4, 2006
    Date of Patent: January 12, 2016
    Assignee: Medigene AG
    Inventors: Axel Mescheder, Matthias Karrasch
  • Treatment of Triple Receptor Negative Breast Cancer
    Publication number: 20150359778
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of “triple receptor negative” breast cancer.
    Type: Application
    Filed: August 24, 2015
    Publication date: December 17, 2015
    Inventors: Kay-Oliver Kliche, Axel Mescheder, Martine Piccart
  • Treatment of triple receptor negative breast cancer
    Patent number: 9144563
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of “triple receptor negative” breast cancer.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: September 29, 2015
    Assignee: Medigene AG
    Inventors: Kay-Oliver Kliche, Axel Mescheder, Martine Piccart
  • Treatment of Triple Receptor Negative Breast Cancer
    Publication number: 20120183604
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of “triple receptor negative” breast cancer.
    Type: Application
    Filed: March 26, 2012
    Publication date: July 19, 2012
    Inventors: Kay-Oliver KLICHE, Axel MESCHEDER, Martine Piccart
  • Treatment of triple receptor negative breast cancer
    Patent number: 8168216
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of ‘triple receptor negative’ breast cancer.
    Type: Grant
    Filed: March 16, 2007
    Date of Patent: May 1, 2012
    Assignee: MediGene AG
    Inventors: Kay-Oliver Kliche, Axel Mescheder, Martine Piccart
  • USE OF ONCOLYTIC VIRUSES AND ANTIANGIOGENIC AGENTS IN THE TREATMENT OF CANCER
    Publication number: 20090317456
    Abstract: The present invention relates to a combination of at least one oncolytic virus and at least one antiangiogenic agent and to the use of this combination in tumor therapy.
    Type: Application
    Filed: October 15, 2007
    Publication date: December 24, 2009
    Applicant: MediGene AG
    Inventors: Matthias Karrasch, Axel Mescheder
  • TREATMENT OF TRIPLE RECEPTOR NEGATIVE BREAST CANCER
    Publication number: 20090186078
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of ‘triple receptor negative’ breast cancer.
    Type: Application
    Filed: March 16, 2007
    Publication date: July 23, 2009
    Inventors: Kay-Oliver Kliche, Axel Mescheder, Martine Piccart
  • Method of administering a cationic liposomal preparation
    Publication number: 20090047337
    Abstract: The present invention relates to the use of pharmaceutical preparations comprising paclitaxel for administration to a human patient in need thereof.
    Type: Application
    Filed: May 4, 2006
    Publication date: February 19, 2009
    Inventors: Axel Mescheder, Matthias Karrasch